5Ridker PM. Clinical application of C- reactive protein for cardiovascular disease detection and prevention [J]. Circulation, 2003, 107: 363 - 369.
6Ridker PM, Stamper M J, Rifai N. Novel risk factors for systemic atherosclerosis : a comparison of C - Reactive protein , fibrinogen, homocysteine, lipoprotein, and tandard cholesterol screening as predictors of peripheral arterial disease[J]. JAMA, 2001, 285:2481-5.
7ISFC/WHO Task Force on Standardization of Clinical Nom enclature and Criteria for Diagnosis of Isehaemic Heart Disease: Nora enclature and Criteria for Diagnosis of Ischaemic Heart Disease[J]. Circul , 1979, 59(3): 607-609.
8Penn MS, Topoi EJ. Tissue factor, the emerging link between in flammation, thrombosis, and vascular remodeling[J].Cir Res, 2001, 89(1): 122.
9Ridker M,Cushman M, Stampfre MJ, et al. Plasma concent ration of C- reactive proteinand risk of developing peripheral vascular disease [J]. Circulation, 1998(97) :425 - 428.
10Sakkinen P, Abbott RD, Carb JD, et al. C- reactive protein and myocardial infarction[J ]. J Clin Epidemiol, 2002,55 (5) : 445.
